THAO DANG: Open Payments
NPI 1285282079 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 70 payments from 21 companies in 2025. Trend: 2023 $1,387 · 2024 $1,569 · 2025 $1,467
Food & beverage: $1,367Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $300 |
| Novo Nordisk Inc | 8 | $260 |
| Renalytix AI, Inc. | 6 | $141 |
| Astellas Pharma US Inc | 2 | $127 |
| Amgen Inc. | 6 | $101 |
| Lilly USA, LLC | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Stryker Corporation | 1 | $50 |
| PFIZER INC. | 2 | $39 |
Products named: QULIPTA, Wegovy, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, REXULTI, UBRELVY, Ozempic, CAPLYTA, CLOTTRIEVER BOLD CATHETER.
Industry payments across TX — which companies pay providers there.
